Advanced breast cancer in elderly patients: which drug after tamoxifen?
Bajetta
Emilio
E
Oncologia Medica B, Istituto Nazionale Tumori, Milan.
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000735:Androstenedione / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D015897:Comorbidity; D019008:Drug Resistance, Neoplasm; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D017698:Postmenopause; D013629:Tamoxifen / Q000494:pharmacology / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D004791:Enzyme Inhibitors; D013629:Tamoxifen; D000735:Androstenedione; C014594:formestane